Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 17, 2007
Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography
Koen Sandra, Mahan Moshir, Filip D'hondt, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 20, 2009
Highly efficient peptide separations in proteomics. Part 2: bi- and multidimensional liquid-based separation techniques
Koen Sandra, Mahan Moshir, Filip D'hondt, et al.
Muscle & Nerve
|
July 2, 2026
Optimization of the Cell-Based Assay Methodology to Study Degradation of Acetylcholine Receptors (Antigenic Modulation) by Antibodies From Myasthenia Gravis Patients
Peng Du, Marina Mané-Damas, Fien M Verhamme, et al.
Mabs
|
October 19, 2013
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo
Johannes Trebing, Isabell Lang, Martin Chopra, et al.
Journal of Immunotoxicology
|
February 13, 2025
Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys
Ornella Binazon, Mario Cocco, Daniel Thwaites, et al.
Mabs
|
February 5, 2014
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade
Karen Silence, Torsten Dreier, Mahan Moshir, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 4, 2026
Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod
Fatemeh Khani-Habibabadi, Fien M Verhamme, Mahan Moshir, et al.
Human Vaccines & Immunotherapeutics
|
March 3, 2025
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models
Prajakta Warang, Gagandeep Singh, Mahan Moshir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2017
Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies
Philippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
Nature Medicine
|
July 1, 2020
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
Carsten Riether, Thomas Pabst, Sabine Höpner, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 17, 2007
Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography
Koen Sandra, Mahan Moshir, Filip D'hondt, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 20, 2009
Highly efficient peptide separations in proteomics. Part 2: bi- and multidimensional liquid-based separation techniques
Koen Sandra, Mahan Moshir, Filip D'hondt, et al.
Muscle & Nerve
|
July 2, 2026
Optimization of the Cell-Based Assay Methodology to Study Degradation of Acetylcholine Receptors (Antigenic Modulation) by Antibodies From Myasthenia Gravis Patients
Peng Du, Marina Mané-Damas, Fien M Verhamme, et al.
Mabs
|
October 19, 2013
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo
Johannes Trebing, Isabell Lang, Martin Chopra, et al.
Journal of Immunotoxicology
|
February 13, 2025
Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys
Ornella Binazon, Mario Cocco, Daniel Thwaites, et al.
Mabs
|
February 5, 2014
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade
Karen Silence, Torsten Dreier, Mahan Moshir, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 4, 2026
Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod
Fatemeh Khani-Habibabadi, Fien M Verhamme, Mahan Moshir, et al.
Human Vaccines & Immunotherapeutics
|
March 3, 2025
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models
Prajakta Warang, Gagandeep Singh, Mahan Moshir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2017
Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies
Philippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
Nature Medicine
|
July 1, 2020
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
Carsten Riether, Thomas Pabst, Sabine Höpner, et al.
Page
of 2